Recently, two cell surface molecules, CD46 (2, 10) and moesin (3), have been identified to be functionally associated with measles virus (MV) susceptibility of cells. CD46, the major MV receptor, can be found in close proximity with moesin at the cell surface, forming a receptor complex (15) . CD46, or MCP (membrane cofactor protein), is a classical transmembrane protein binding the complement proteins C3b and C4b and inhibiting lysis of host cells by complement (7, 8) . The binding of MV to CD46 is dependent on its N glycosylation, which probably is necessary for the proper conformation of this molecule (9) . Following infection with MV strain Halle, CD46 is strongly downregulated from the surface of the host cell (11) . All MV vaccine strains tested to date, including Edmonston and CAM, modulated the cell surface expression of CD46, whereas lymphotropic wild-type isolates did not downregulate CD46 following infection (16) . Vaccinia virus-encoded recombinants expressing MV hemagglutinin (MV-H) from different strains exert these differential effects on CD46 downregulation (16) . Since the normal cellular function of CD46 in vivo is to inhibit the deposition of the complement proteins C3b and C4b on host cells, a consequence of the modulation of CD46 following MV infection is the increased susceptibility of cells to complement lysis (17) .
The recently observed differences in nucleotide sequences and biological properties of MV strains suggest that the heterogeneity of MV strains may be greater than had originally been thought. For the investigation of these differences, it is important to take into account that the method chosen for the isolation of individual MV strains will exert selective pressure upon the original virus population and will promote the growth of variants better able to adapt to growth in cell culture. Classically, MV strains were established by passage of infected blood or biopsy material of patients in Vero cells. However, it has been noted that MV-induced fusion occurs more rapidly after infection of a marmoset B-lymphocytic line (B95a) and that these cells were much more sensitive to infection with material obtained from patients (4, 5) . Therefore, strains of MV isolated by passage in lymphocytes are thought more likely to resemble the circulating wild-type strains than those obtained by Vero cell passage.
In addition to the 19 MV strains described (16), we investigated 15 further wild-type isolates: BIL (18); CL, SE, TT, Y22, and R118 (12); JM (1); AK-4 (13); EB-L and EB-T (14); Kohno (6); and YL-B3, YT-B3, YL-V4, and YT-V4. The cells used for isolation, the country of origin, the year of isolation, and the results concerning CD46 modulation after infection of human target cells with these strains are presented in Table 1 . Of the 15 new strains, 4 (BIL, CL, TT, and Y22) led to the downregulation of CD46 and 11 did not. Figure 1 shows the surface expression of CD46 on B95a, Raji, and HeLa cells, which were infected with seven representative MV strains before having CD46 expression tested by flow cytometry as described elsewhere (16) . The MV strains TT and Y22 modulated CD46 expression by approximately 40 and 50% and strain CL modulated CD46 expression by only approximately 30%, whereas strains YL-B3, YT-B3, SE, and R118 did not induce downregulation of CD46 (Fig. 1A, C , and E). The level of infection for all strains was standardized on the basis of the expression of MV-H (Fig. 1B, D, and F) .
Since the procedure for virus isolation and passages in certain cell types might have led to the selection of MV strains with differences in lymphotropism, we tested this hypothesis with isolates derived from a throat swab (T) and peripheral blood mononuclear cells (L) from a single MV patient using B95a cells (Epstein-Barr virus-transformed marmoset leukocytes) and Vero cells (African green monkey kidney cells). The resulting strains were designated YT-V4, YT-B3, YL-V4, and YL-B3 (Fig. 2) . In addition to these four strains, we tested the MV strains EB-T and EB-L, which were derived from a different MV patient from a throat swab (T) and peripheral blood mononuclear cells (L) by cultivation on Vero cells. None of these isolates led to the downregulation of CD46 after infection of B95a cells (results for YL-B3 and YT-B3 are shown in Fig. 1A ) and BJAB cells (transformed human B lymphocytes [data not shown]). These results suggest that neither the cell type nor the source of infectious material directly deter-mines the phenotype of a particular virus isolate from a single source.
We further investigated whether the phenotype of an MV strain, with respect to CD46 modulation, is altered by adaptation of a lymphotropic CD46 nondownregulating strain to Vero or HeLa cells. The lymphotropic MV strains DL and WTF were adapted to nonlymphocytes by repeated (at least 30) passages over Vero cells. We then tested their capacity to modulate CD46 expression after infection of HeLa cells. At no time was the phenotype of the MV strains altered with respect to CD46 downregulation, although the potential for infecting fibroblasts was clearly improved by the adaptation process (data not shown).
Since neither the isolation procedure nor the adaptation in cell culture changed the potential of these strains to modulate CD46, we suggest that this is an intrinsic property of a particular MV strain dependent on the sequence of its H protein and that selection from a mixed virus population is unlikely. The degree of downregulation observed after infection of human cells with MV strains BIL and CL was only 25 to 30%, whereas the degree of downregulation of CD46 observed with other modulating MV strains was between 40 and 80%. With 10% reduction of CD46 expression, the MV strain SE was classified as nondownregulating under the stringencies we set for the interpretation of the results. These data suggest that certain strains might represent intermediate variants of MVs between extremely downregulating and nondownregulating forms. It would be interesting to know what role the receptor downregulation has in vivo and whether nondownregulating variants might occur by antigenic drift directed by evolutionary pressure. 
